Atrium divests chemicals division

Executive Summary

Health and nutrition product marketer Atrium has completed the sale of its active ingredients and specialty chemicals division to Unipex Group for $166.4 million in cash, "subject to post-closing working capital adjustment," the company announces May 22. Proceeds will provide the firm better financial flexibility to pursue its corporate strategy, the Quebec City, Canada-based company notes. With the sale, Atrium has reached its goal of focusing entirely on health and nutrition products (1"The Tan Sheet" Jan. 6, 2008, In Brief)...